FINCH THERAPEUTICS GROUP, INC. Shareholders' Equity
FINCH THERAPEUTICS GROUP, INC. had Shareholders' Equity of $14.22 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-08-13
- 2024-06-30: Stockholders' Equity Attributable to Parent $14.22M.
- 2024-03-31: Stockholders' Equity Attributable to Parent $19.04M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $22.89M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $25.81M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2024-06-30 | $14.22M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $19.04M 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $22.89M 10-Q · filed 2024-08-13 | |
| 2023-09-30 | $25.81M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $27.89M 10-Q · filed 2024-08-13 | |
| 2023-03-31 | $34.54M 10-Q · filed 2024-08-13 | $32.95M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $95.71M 10-Q · filed 2024-08-13 | |
| 2022-09-30 | $120.87M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $159.09M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $179.79M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $202.22M 10-K · filed 2024-03-25 | |
| 2021-09-30 | $219.80M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $228.19M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $239.46M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | -$95.72M 10-K · filed 2023-03-23 | |
| 2020-09-30 | -$85.53M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$75.51M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | -$67.34M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | -$59.53M 10-K · filed 2022-03-31 |